Physician profile
Brian Williams
NPI 1548436660
$33,441.59
in general payments reported to CMS, 2019-2025
24 companies · $2,130 in 2025
The $2,130 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $339 · 2020: $2,568 · 2021: $12.72 · 2022: $21K · 2023: $918 · 2024: $6,116 · 2025: $2,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,572 · Food and Beverage: $3,218 · Travel and Lodging: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,571.55 |
| Food and Beverage | $3,217.68 |
| Travel and Lodging | $374.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collagen Matrix, INC | $24,262.15 | 2022-2024 | |
| Novocure INC. | $2,887.64 | 2019-2025 | Optune, Optune Gio |
| Medtronic, INC. | $2,370.54 | 2021-2025 | Stealthstation S8 Platform, Strata, Minimed 780g |
| Gt Medical Technologies, INC | $1,029.16 | 2022-2025 | Gammatile, Gammatile |
| Lilly USA, LLC | $374.76 | 2023 | |
| Surgical Theater. INC. | $360.18 | 2025 | |
| Cerapedics INC. | $260.69 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Si-Bone, INC. | $243.94 | 2022-2023 | |
| Depuy Synthes Sales INC. | $221.16 | 2024-2025 | Vivigen Mis Delivery System, Velys, Acis |
| Medtronic USA, INC. | $204.56 | 2019-2020 | |
| Globus Medical, INC. | $197.94 | 2025 | Excelsius Gps, Tlif |
| Telix Pharmaceuticals | $141.33 | 2025 | Illuccix |
| Zimmer Biomet Holdings, INC. | $132.51 | 2025 | Neuro Plating System |
| Monteris Medical Corporation | $129.73 | 2022 | |
| Esperion Therapeutics, INC. | $124.97 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $123.85 | 2022 | |
| Dixi Medical USA Corp | $103.34 | 2023 | |
| Stryker Corporation | $95.15 | 2023-2024 | Duramatrix, Sonopet Iq |
| Servier Pharmaceuticals LLC | $46.49 | 2025 | |
| Azurity Pharmaceuticals, INC. | $30.14 | 2023 | Gliadel |
| Dendreon Pharmaceuticals LLC | $29.73 | 2019 | |
| Kls-Martin L.P. | $27.65 | 2023 | |
| Jazz Pharmaceuticals INC. | $27.52 | 2025 | |
| Kyowa Kirin, INC. | $16.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.